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Edited by Masayuki MiyasakaAbstract Interleukin-21 (IL-21) has pleiotropic functions on
the cells, which play roles in both innate and acquired immunity,
such as T cells, B cells, natural killer (NK) cells and dendritic
cells. In this study we identiﬁed a novel isoform of IL-21, IL-
21iso in human and mouse. IL-21iso might be an alternative
splicing variant form and the C-terminal region of predicted
IL-21iso amino acid sequences were diﬀerent from original IL-
21 in both human and mouse. In spite of the diﬀerences in C-ter-
minal amino acid sequences, both human IL-21 and IL-21iso
showed comparable proliferative eﬀect on anti-CD40 Ab-acti-
vated primary B cells, anti-CD3 Ab-activated primary T cells
and human NK cell line, NK0, and upregulated IFN-c produc-
tion from NK0. Furthermore IL-21 and IL-21iso similarly acti-
vated STAT1 and STAT3. IL-21iso mRNA was expressed in
activated T cells as well as IL-21 mRNA. However, cyclohexi-
mide treatment partially blocked the upregulation of IL-21iso
mRNA in activated T cells while little aﬀected the IL-21 mRNA
expression suggesting that de novo protein synthesis is required
for the full expression of IL-21iso transcript. We also show that
the secretion eﬃciency of hIL-21iso is much lower than that of
hIL-21. These results may suggest there are some diﬀerent reg-
ulatory mechanisms to produce IL-21 or IL-21iso in transcrip-
tional and secretory steps.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Interleukin-21 (IL-21) is a T cell-derived cytokine, which was
discovered in 2000 with its receptor (IL-21R) [1,2]. IL-21 is
most similar to IL-2, IL-4 and IL-15 whereas IL-21R has
structural similarity with IL-2Rb and IL-4Ra. IL-21 is a mem-
ber of the common c chain (cc)-dependent cytokine family that
includes IL-2, IL-4, IL-7, IL-9 and IL-15 [3,4]. Because X-
linked severe combined immunodeﬁciency (X-SCID) is caused
by cc mutations in a gene on the X chromosome [5], it was
expected that IL-21 dysfunction had important roles in theAbbreviations: Ab, antibody; mAb, monoclonal antibody; PMA,
phorbol 12-myristate 13-acetate; SDS–PAGE, sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis
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doi:10.1016/j.febslet.2007.07.034pathogenesis of X-SCID. In fact, IL-21R/IL-4 double-deﬁcient
mice showed B cell dysfunction as X-SCID patients [6].
IL-21R is preferentially expressed on B cells, T cells, natural
killer (NK) cells, some myeloid cells, and keratinocytes [1,7,8].
Therefore, IL-21 has diverse functions on various immune cells
of innate and adaptive immunity [1,9]. IL-21 costimulates the
proliferation of activated T cells and induces the diﬀerentiation
of B cells into memory cells and plasma cells [1,10]. Interest-
ingly, IL-21 suppresses IgE production through inhibition of
germ line Ce transcription and Be cell apoptosis [11,12]. On
NK cells diﬀerent biologic eﬀects of IL-21 between human
and mouse are reported. Human IL-21 (hIL-21) enhances
NK cell cytotoxic activity and NK cell proliferation while
mouse IL-21 (mIL-21) enhances NK activity but inhibits NK
cell proliferation [1,9,13,14]. IL-21 inhibits dendritic cell acti-
vation and maturation [15] and lipopolysaccharide-induced
cytokine production in human monocyte-derived dendritic
cells [16]. Moreover, IL-21 might have a role in the develop-
ment of autoimmunity [10,17,18] and many reports show its
anti-tumor activities [19] suggesting that the function of hIL-
21 is closely related in human diseases including tumor devel-
opment.
During an analysis of IL-21 transcripts with RT-PCR meth-
od, we found additional products in human and mouse. We
have cloned them and DNA sequence analysis showed that
the clones were IL-21isoforms, IL-21iso. Among the cc-depen-
dent cytokine family, human IL-2 and human IL-4 isoforms
were reported to be competitive inhibitors to the original IL-
2 and IL-4, respectively [20,21]. On the other hand, human
IL-21iso (hIL-21iso) has comparable function with hIL-21
on the proliferation of anti-CD40 Ab-activated B cells, anti-
CD3 Ab-activated T cells and human NK cell line, NK0 cells
and on the IFN-c production from NK0 cells. We also show
that IL-21 and IL-21iso are diﬀerentially regulated in the tran-
scriptional and cytokine secretory steps.2. Materials and methods
2.1. Cells and antibodies
Peripheral blood mononuclear cells (PBMC) were isolated from hep-
arinized whole blood of healthy donors by density gradient centrifuga-
tion using Ficoll-Paque Plus (Amersham Pharmacia Biotech.,
London, UK) according to the manufacturer’s instructions. Isolated
PBMC were maintained in RPMI1640 medium supplemented with
10% heat-inactivated FBS, penicillin and streptomycin. B cells were
puriﬁed from PBMC with anti-CD19 magnetic beads after depleting
monocytes with anti-CD14 magnetic beads (BD Biosciences Pharmin-
gen, San Diego, CA). To purify CD4+ T cells, both CD14+ cells andblished by Elsevier B.V. All rights reserved.
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netic beads (BD Biosciences Pharmingen). Human NK cell line NK0
cells were maintained in RPMI1640 medium supplemented with 10%
heat-inactivated FBS, 1 nM recombinant human IL-2 (rhIL-2, R&D
Systems, Minneapolis, MN, USA), 100 mM sodium pyruvate, MEM
non-essential amino acids, penicillin and streptomycin [22]. Ba/F3 is
an IL-3-dependent murine pro-B cell line and the subline, BAF3-6 cell,
lacks IL-21R expression [23]. We prepared human IL-21R (hIL-21R)
cDNA from total RNA of human peripheral blood B cells and cloned
into pEFneo expression vector plasmid [23]. BAF21RWT-1 cell line
was established by introducing hIL-21R expression vector plasmid,
pEFneohIL-21R, into BAF3-6 cells. The expression level of hIL-21R
on the BAF21RWT-1 cell was determined by ﬂow cytometry with
anti-hIL-21R monoclonal antibody (mAb) (clone 17A12, unpublished
data). BAF3-6 and BAF21RWT-1 cells were maintained in RPMI1640
medium supplemented with 10% heat-inactivated FBS, 50 lM 2-
mercaptoethanol, 15% conditioned medium of WEHI3 cells as a
source of IL-3, penicillin and streptomycin. 293T cells were maintained
in Dulbecco’s modiﬁed Eagle’s medium (DMEM) supplemented with
10% heat-inactivated FBS, penicillin and streptomycin. Mouse spleno-
cytes from ICR mice aged 8–12 weeks were maintained in RPMI1640
medium supplemented with 10% heat-inactivated FBS and 50 lM 2-
mercaptoethanol. These cells were cultured at 37 C in a humidiﬁed
incubator with 5% CO2. Anti-human CD3 mAb (UCHT1) and
FITC-labeled anti-human IFN-c mAb were purchased from BD Bio-
sciences Pharmingen. Anti-human CD40 mAb (S2C6) was purchased
from Mabtech AB. Anti-phospho-STAT1 (Y701) Ab, anti-phospho-
STAT3 (Y705) Ab and HRP-conjugated anti-rabbit IgG Ab were pur-
chased from Cell Signaling Technology (Beverly, MA) and anti-Fig. 1. Cloning of a novel IL-21 isoform in human. (A) Schematic structure o
is indicated as i4. Positions of primers used for PCR are shown as arrows. (B)
healthy donors were ampliﬁed by PCR using hF1 and hR1 primers. M indicat
before () and after activation with anti-human CD3 mAb (+) for 6 h were am
between hIL-21 and hIL-21iso. Additional DNA sequences of hIL-21iso areSTAT1 Ab and anti-STAT3 Ab were purchased from Santa Cruz Bio-
technology, Inc. (Santa Cruz, CA). We prepared anti-hIL-21 mAb
(4BG1) and anti-hIL-21 polyclonal Ab by ourselves (manuscript in
submission). All human specimens were obtained under informed con-
sent. The protocol for the human research has been approved by the
Ethics Committee of Yamagata University Faculty of Medicine. All
mouse experiments were performed in accordance with the guidelines
of the Laboratory Animal Center of Yamagata University Faculty
of Medicine and were approved by the animal experiment committee
of Yamagata University Faculty of Medicine.
2.2. RNA extraction and RT-PCR
Human CD4+ T cells or mouse spleen cells were treated with or
without cycloheximide (Sigma, St. Louis, MO), phorbol 12-myristate
13-acetate (PMA) (Sigma) or ionomycin (Sigma) as indicated. Total
cellular RNA was isolated from these cells using TRIzol Reagent
(Invitrogen, San Diego, CA). First strand cDNA was synthesized from
1 lg of total RNA using AMV Reverse Transcriptase and oligo (dT)
primer with cDNA synthesis kit (Life Sciences, Inc., St. Petersburg,
FL) according to the manufacturer’s instructions. The synthesized
ﬁrst-strand cDNAs were ampliﬁed by PCR using primers for IL-21,
IL-21iso, IL-2 or b-actin with TaKaRa TaqTM HS (TaKaRa Bio
Inc. Kyoto, Japan). Primers used in this study are described as
follows, for total hIL-21: hF1 5 0-AAGGTACCACTTATGA-
GATCCAGTCCT-3 0 and hR1 5 0-AAACTAGTCAACTGCAAGT-
TAGATCCT-30, speciﬁc for hIL-21iso: hF2 5 0-CCAACTAAAGTCA-
GCAAATACAGG-3 0 and hR2 5 0-GTGAGTAACTAAGAAG-
CAAATCTGG-3 0, speciﬁc for hIL21: hF3 5 0-CACTTCTCCAAAA-
GATGAT-30 and hR3 5 0-ATCCTGACTTTGCACACT-3 0, forf hIL-21 gene. Exons are indicated as boxes with numbers and intron 4
cDNAs prepared from anti-human CD3 mAb activated PBMC from 3
es 100 bp DNA ladder marker. (C) cDNAs prepared from CD4+ T cells
pliﬁed by PCR using hF2 and hR2 primers. (D) Sequence comparison
underlined. Asterisk (*) indicates the conceptual stop codon.
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and 5 0-ACAGAACTGAAACATCTTCAGTGTC-30, for human-b-
actin: hb-actinF 5 0-CGACAGGATGCAGAAGGAGATCAC-3 0 and
hb-actinR 5 0-CGTCATACTCCTGCTTGCTGATCC-3 0, for total
mIL-21: mF1 5 0-AAGGTACCATGGAGAGGACCCTTGT-3 0 and
mR1 5 0-AAACTAGTATGTACTCCTGCATTCGTG-30, speciﬁc for
mIL-21iso: mF2 5 0-GAGGAAAGAAACAGAAGCACA-3 0 and
mR2 5 0-AGACACAACATGGAAGTGAAA-3 0, speciﬁc for mIL-21:
mF3 5 0-TGGCTCCTTCAAAAGATGAT-3 0 and mR1, for mouse
IL-2 (mIL-2): 5 0-GTTGTAAAACTAAAGGGCTCTGAC-3 0 and 5 0-
GTTGAGATGATGCTTTGACAGAAG-3 0, for mouse b-actin: 5 0-
TGACAGGATGCAGAAGGAGA-3 0 and 5 0-GCTGGAAGGTGG-
ACAGTGAG-3 0. Underlined sequences are restriction enzyme recog-
nition sites for the DNA cloning in expression plasmid vectors.
Real time quantitative PCR ampliﬁcations were conducted using
SYBR Green Realtime PCR Master Mix (Toyobo Co. Ltd. Osaka,
Japan) according to the manufacturer’s instructions, with 0.2 lM
primers and cDNAs or a variable amount of DNA standard (pEFneo-
hIL-21, pEFneohIL-21iso and pBShbactin for hIL21, hIL-21iso, and
human b-actin, respectively) in a 20ll ﬁnal reaction volume. Thermo-
cycling was performed using a LightCycler (Roche Molecular System
Inc. Pleasanton, CA) initiated by a 30 s incubation at 95 C, followed
by 40 cycles (95 C, 5 s; 50 C, 5 s; 72 C, 20 s) with a single ﬂuorescent
reading taken at the end of each cycle. Each run was completed with a
melting curve analysis to conﬁrm the speciﬁcity of ampliﬁcation and
lack of primer dimers. Ct values were determined using a ﬂuorescence
threshold set manually for all runs and exported into a MS Excel
workbook (Microsoft Inc.) for analysis. hIL-21 or hIL-21iso mRNA
expression level was normalized by dividing its relative mRNA amountFig. 2. Cloning of a novel IL-21 isoform in mouse. (A) Schematic structure o
is indicated as i4. Positions of primers used for PCR are shown as arrows.
ionomycin for 6 h. cDNAs prepared from these cells were ampliﬁed by PCR u
between mIL-21 and mIL-21iso. Additional sequences of mIL-21iso are undwith the corresponding b-actin mRNA amount. Primers used in the
real time quantitative PCR are as follows, for hIL-21: hF3 and hR1,
for hIL-21iso: hF2 and hIL-21isoSpeR 5 0-AAACTAGTAAAGA-
TAAAGCAGAAAAT-30, for human b-actin: hb-actinF and hb-ac-
tinR.
2.3. IL-21 isoform cloning and construction of expression plasmid
Extra bands in human and mouse IL-21 PCR products were puriﬁed
using hF1/hR1 or mF1/mR1 primers and digested with restriction en-
zymes, KpnI and SpeI. The digested fragments were ligated to pEFneo
mammalian expression vector [23] and the nucleotide sequences were
analyzed by ABI PRISM 310 genetic analyzer (Applied Biosystems,
Foster City, CA).
2.4. Cytokine production and quantiﬁcation
293T cells were transfected with the hIL-21 or hIL-21iso expression
vectors pEFneohIL-21 or pEFneohIL-21iso, respectively, or an empty
vector, pEFneo, as a control by calcium-phosphate transfection meth-
od as previously described [24]. The supernatants were collected 48 h
after transfection. The concentration of the hIL-21 and hIL-21iso in
the supernatants was measured by immunoblot assay using anti-hIL-
21 polyclonal Ab. These supernatants were used to stimulate cells in
this study.
2.5. Cell proliferation assays
BAF3-6 and BAF21RWT-1 cells were cultured in 96-well ﬂat-bot-
tomed plates in triplicate with either hIL-21, hIL-21iso or recombi-
nant mouse IL-3 (rmIL-3, R&D Systems, Minneapolis, MN, USA)f mIL-21 gene. Exons are indicated as boxes with numbers and intron 4
Mouse spleen cells were cultured with (+) or without () PMA and
sing mF1 and mR1 (B) or mF2 and mR2 (C). (D) Sequence comparison
erlined. Asterisk (*) indicates the conceptual stop codon.
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CD40 mAb were cultured in 96-well ﬂat-bottomed plates in triplicate
with hIL-21, hIL-21iso or recombinant hIL-21 (rhIL-21, Biosource
International, Camarillo, CA, USA) for 3 days. Puriﬁed CD4+ T cells
were cultured in triplicate with hIL-21 or hIL-21iso in 96-well ﬂat-
bottomed plates pre-coated with anti-human CD3 mAb (1 lg/ml),
for 3 days. NK0 cells were washed three times with PBS and then cul-
tured with or without hIL-21, hIL-21iso, rhIL-21 or rhIL-2 for 24 h.
Then alamarBlue (BioSource Int. Inc. Camarillo, CA) was added to
10% of the total culture medium volume. Cells were cultured for an
additional 24 h and absorbance was measured at 595 and 570 nm
by plate reader. Because alamarBlue is more reduced in the prolifer-
ating cells than in the non-proliferating cells, cell proliferation was
quantiﬁed as alamarBlue reduction. The percent alamarBlue reduced
(%reduction) was calculated according to the manufacturer’s instruc-
tion.
2.6. Functional assay on NK0 cells
To examine the functions of hIL-21 and hIL-21iso on human NK
cell, we assessed the IFN-c production from NK0 cells after hIL-21
or hIL-21iso treatment by intracellular staining with FITC-labeled
anti-human IFN-c antibody according to the manufacturer’s instruc-
tion (BD Biosciences Pharmingen). Stained cells were analyzed by
FACSCalibur (BD Biosciences, San Jose, CA).Fig. 3. Kinetics of IL-21 and IL-21iso mRNA expression. Human CD4+ T
(10 lg/ml) for 1 h, and then stimulated with PMA (50 ng/ml) and ionomycin
mouse spleen cells were also treated with PMA (50 ng/ml) or ionomycin (1 lM
were used as templates for each PCRs. M and NC indicate 100 bp DNA ladd
quantitative PCR experiments were performed as described in Section 2 with
21 and hIL-21iso were normalized with that of corresponding b-actin as indica
experiments are shown.2.7. Cell extraction and immunoblot assay
Cells were stimulated with hIL-21 or hIL-21iso at 1 nM concentra-
tion for 30 min. Cell extraction and immunoblot assay are described
previously [23].3. Results and discussion
3.1. Cloning of a novel IL-21 isoform
IL-21 is exclusively expressed from activated CD4+ T cells.
In order to examine the expression level of hIL-21 mRNA,
we employed RT-PCR with hF1 and hR1 primers, allowing
ampliﬁcation of the entire coding region (Fig. 1A). Total
RNA of anti-CD3 mAb-stimulated human PBMC was sub-
jected to RT-PCR analysis and the products of the appropriate
size (526 bp) were observed as expected. In addition, however,
a larger band was also consistently observed (Fig. 1B). Nested
PCR of the larger band using two inside primers indicated that
the additional product might be derived from a hIL-21 tran-
script (data not shown). The larger product was isolated and
the DNA sequences were analyzed. Interestingly, it was identi-cells or mouse spleen cells were treated with or without cycloheximide
(1 lM) for the indicated periods (A and E). Human CD4+ T cells or
) separately as indicated (B and F). cDNAs prepared from these cells
er marker and negative controls without cDNA, respectively. Real time
cDNA used in (A) and (B) (C and D). mRNA expression levels of hIL-
ted in Section 2. Representative results from at least 2 to 3 independent
Fig. 3 (continued)
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known sequences. Data base search revealed that the 90 bp se-
quences are intron 4 sequences (i4) between exon 4 and exon 5
of already reported hIL-21 gene (Fig. 1A and D). We named
this product hIL-21iso. This result indicates that maturemRNAs of hIL-21iso and hIL-21 are processed from the same
pro-mRNA and hIL-21iso is an alternative splicing variant
form. In the RT-PCR experiments we used oligo (dT) primer
to prepare cDNA from total RNA indicating that only mature
mRNAs might be ampliﬁed. Therefore we excluded a possibil-
Fig. 4. Production of hIL-21 and hIL-21iso. (A) Cytokines in the
supernatants of 293T cells transfected with pEFneo (empty vector),
pEFneohIL-21iso or pEFneohIL-21 were detected by immunoblot
assay using aﬃnity puriﬁed anti-hIL21 polyclonal Ab. rhIL-21 were
used as positive controls. The amounts of loaded supernatants are
indicated. (B) Intracellular cytokines expressed in 293T cells transfec-
ted with pEFneo (empty vector), pEFneohIL-21iso or pEFneohIL-21
were detected by immunoblot assay using anti-hIL21 polyclonal Ab.
10 lg of each total cell extracts were used for assay. 10 ng rhIL-21 was
used as a positive control.
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splicing. Since the additional 90 bp sequences include an in-
frame stop codon, hIL-21iso is 9 amino acids shorter than
the original hIL-21. So the predicted amino acid number of
hIL-21iso precursor protein is 153 and mature hIL-21iso con-
sists of 122 amino acids. To detect the hIL-21iso transcript
clearly, we designed new primer set speciﬁc to hIL-21iso
(hF2 and hR2) (Fig. 1A). CD4+ T cells were isolated from
PBMC and stimulated with or without anti-human CD3
mAb. RT-PCR using the IL-21iso speciﬁc primers demon-
strated that hIL-21iso expression was found only in activated
CD4+ T cells (Fig. 1C).
Consequently, we hypothesized isoforms similar to hIL-
21iso also exist in mouse. As expected, we found an additional
larger band than 538 bp band in the ampliﬁed products from
RT-PCR using mF1 and mR1 primers and cDNA prepared
from PMA and ionomycin-stimulated mouse spleen cells
(Fig. 2B). Similar to the human isoform, the additional band
found in mouse contains the intron 4 sequences (i4) between
the exons 4 and 5 of mIL-21 gene (Fig. 2A and D). This addi-
tional sequence in mIL-21iso also has an in-frame stop codon.
The predicted mIL-21iso precursor protein contains 162 amino
acids and mature mIL-21iso consists of 138 amino acids that is
16 amino acids longer than that of mIL-21. We conﬁrmed that
the mIL-21iso transcript was only found in activated spleen
cells using mIL-21iso speciﬁc primer set (mF2 and mR2)
(Fig. 2C). The sequences of hIL-21iso and mIL-21iso reported
in this paper have been deposited in GenBank Accession Nos.
DQ645417 and DQ645418, respectively.
Next we tried to detect IL-21 and IL-21iso protein by
Western blotting but we could not detect both of them (data
not shown). The amount of these proteins produced from
activated CD4+T cells might be less than the detection level.
3.2. Kinetics of IL-21 and IL-21iso mRNA expression
First, we compared the kinetics of IL-21 and IL-21iso
mRNA expression in activated human CD4+ T cells or
mouse spleen cells by RT-PCR. Both human and mouse
IL-21 and IL-21iso mRNA expressions were detected within
1 h after PMA and ionomycin stimulation and then upregu-
lated, though a little transcript of IL-21 but not of IL-21iso
was detected before stimulation (Fig. 3A, C and E). IL-21
and IL-21iso mRNA expressions persisted even at 48 h after
stimulation (data not shown). As an internal control, we
examined the level of b-actin mRNA. Although the expres-
sion patterns of IL-21 and IL-21iso were similar, the real time
quantitative PCR experiments showed that the mRNA
expression level of hIL-21iso was much lower than that of
hIL-21 (Fig. 3C).
Cycloheximide treatment of human CD4+ T cells or mouse
spleen cells, which was conducted 1 h before the PMA and ion-
omycin stimulation, initially inhibited the expression of IL-21
mRNA partially but later on enhanced it, whereas cyclohexi-
mide inhibited mRNA expression of hIL-21iso moderately
and signiﬁcantly of mIL-21iso (Fig. 3A, C and E). These re-
sults indicate that IL-21iso mRNA expression depends on in
part de novo protein synthesis. The cycloheximide induced-
slight upregulation of IL-21 mRNA after activation was re-
ported previously [25], and was similar to that of IL-2 mRNA
as Zubiaga et al. reported [26]. These results suggest that there
are diﬀerent regulatory mechanisms between IL-21, IL-2 and
IL-21iso mRNA expression.Kim et al. reported that mIL-21 gene is activated with only
ionomycin treatment [25]. We also observed that ionomycin
treatment alone upregulated both IL-21 and IL-21iso mRNA
expressions in human and mouse, whereas PMA alone could
not (Fig. 3B, D and F). Because primers, which Kim et al. used
to determine the mIL-21 mRNA levels, are on the 3 0-UTR that
is common to both mIL-21 and mIL-21iso transcripts, iono-
mycin-induced activation of mIL-21 gene in their study may
reﬂect the up-regulation of both mIL-21 and mIL-21iso
mRNA.
So far many cytokine isoforms have been reported. Even
among the cc-dependent cytokines, IL-2, IL-4, IL-7 and IL-
15 are known to have isoforms [20,21,27–29]. However, the
control mechanisms for the isoform transcripts are largely un-
known. We speculate that certain splicing negative regulatory
molecules may be produced in these cells. Without these mol-
ecules due to the treatment of cycloheximide, intron 4 of pre-
mature IL-21 mRNA is spliced out and only mature IL-21
mRNA is prepared, however, in the presence of these mole-
cules the splicing is partially inhibited and IL-21iso mRNA
may be produced. Nucleotide sequences around 5 0 splice site
Fig. 5. Eﬀect of IL-21 and IL-21iso on cell proliferation and IFN-c production. Cell culture conditions, cell proliferation assay and IFN-c
production assay were described in Section 2. BAF3-6 and BAF21RWT-1 were stimulated with empty vector-transfected 293T cell supernatant, hIL-
21iso, hIL-21 or rmIL-3 as indicated. CD19+ B cells were stimulated with or without anti-CD40, and hIL-21iso, hIL-21 or rhIL-21 as indicated.
CD4+ T cells were cultured on anti-CD3 pre-coated plate and stimulated with hIL-21iso or hIL-21 as indicated. NK0 cells were stimulated with
empty vector-transfected 293T cell supernatant, hIL-21iso, hIL-21, rhIL-21 or rhIL-2 as indicated. Mean ﬂuorescence intensity (MFI) are shown for
IFN-c production assay. We stimulated cells with 25 ng/ml hIL-21iso, hIL-21 or rhIL-21, 1 ng/ml rmIL-3 or 1 nM rhIL-2 for each assay.
Representative data are shown from three independent experiments.
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However, several studies have shown that exonic and intronic
sequences in additional to the well-conserved donor and accep-
tor sites may play a role in nuclear pre-mRNA splicing [30]. A
genome wide survey shows that intron retention event (as in
the case of IL-21iso) is usually found in genes with shorter in-
trons (less than 200bp) but it is rarer than any other forms of
alternative splicing [31]. Interestingly, dramatically higher fre-
quency of exonic splicing silencers or depletion of exonic splic-
ing enhancers is found in intron retention both in human and
mouse [31]. Further studies are required to reveal the presence
of any silencer or enhancer elements in IL-21 gene and some
regulatory molecules involving in the splicing events.3.3. Secretion of hIL-21iso
To produce hIL-21 and hIL-21iso, we transfected 293T
cells with pEFneohIL-21 or pEFneohIL-21iso and the super-
natants were subjected to SDS–PAGE and immunoblot assay
using anti-hIL-21 mAb. We detected a single band of hIL-
21iso with a little smaller size of molecular mass compared
to a 293T cell expressed-hIL-21 and a control recombinant
hIL-21 (Fig. 4A). Transfection eﬃciency of pEFneohIL-21
and pEFneohIL-21iso or produced amount of each protein
in these cells had no diﬀerences (Fig. 4B and data not shown).
However, secreted amount of hIL-21iso was approximately
20-fold lower than that of hIL-21 (Fig. 4A). Similarly, re-
duced secretion of hIL-21iso was also found in COS7 and
Fig. 6. STATs activation by hIL-21 or hIL-21iso. Cells were stimulated with hIL-21iso, hIL-21 or rhIL-21 as indicated for 30 min. Tyrosine-
phosphorylated STATs were detected with anti-phospho STAT3 (pY705) or anti-phospho STAT1 (pY701) Abs. Membranes were reprobed with
anti-STAT3 or anti-STAT1 Abs to conﬁrm the protein levels. Protein molecular weight marker and the positions of each STAT are indicated.
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21 (data not shown). Transcripts of IL-15 isoforms are
known to have diﬀerent translational eﬃciencies [29]. In our
expression system, we could not ﬁnd the diﬀerent transla-
tional eﬃciencies between hIL-21 and hIL-21iso. The C-ter-
minal diﬀerences between hIL-21 and hIL-21iso must be
involved in the control of the secretory eﬃciency. hIL-21iso
might work in the cells regulating cytokine signaling because
produced hIL-21iso mainly remains in the cytoplasm and
hIL-21-producing CD4+T cells express both hIL-21 receptor
and cc (data not shown).
3.4. Functional assay
Parrish-Novak et al. has already reported that hIL-21 in-
duced proliferation of BaF3 cell line expressing IL-21R [1].
To check the function of hIL-21iso, we prepared hIL-21R-
expressing BaF3 subline, BAF21RWT-1. hIL-21iso induced
cell proliferation of BAF21RWT-1 but not of BAF3-6 parent
cells and the supernatant from empty vector-transfected 293T
cells had no functions on both cell lines (Fig. 5). Taken to-
gether, these results show that hIL-21iso transduces cell prolif-
eration signals through a cognate receptor, IL-21R. hIL-21
costimulates proliferation of anti-CD40 Ab-activated B cells
[1]. Similar to hIL-21, hIL-21iso costimulated proliferation
of anti-CD40 mAb-induced CD19+ B cells (Fig. 5). Also, we
did not ﬁnd any signiﬁcant diﬀerences between the eﬀect of
hIL-21iso and hIL-21 on the proliferation of anti-CD3 mAb-
activated CD4+ T cells and on NK0 cells (Fig. 5). IL-21 is
known to induce IFN-c synthesis from human NK cells [32].
IFN-c production from NK0 cells was increased after stimula-
tion with hIL-21iso and hIL-21 (Fig. 5).3.5. IL-21iso induced activation of STATs
IL-21 induces phosphorylation of STAT1 and STAT3 [3]. In
order to compare signaling ability of IL-21iso and IL-21,
BAF21RWT-1 cells, PBMC and NK0 cells were stimulated
with either hIL-21iso or hIL-21. These cell extracts were sub-
jected on SDS–PAGE and immunoblot assay with Abs speciﬁc
for tyrosine phosphorylated STAT1 and STAT3. hIL-21iso in-
duced tyrosine phosphorylation of STAT1 and STAT3 as well
as hIL-21 in BAF21RWT-1 cells and NK0 cells while a little
weakly in PBMC (Fig. 6). Mutations Q145D, I148D, and
I148Stop within helix D of IL-21 were reported to reduce sig-
naling capability but not to aﬀect the receptor-binding charac-
teristics [33]. Although the C-terminal 7 amino acids (amino
acid Nos. 147–153) of hIL-21iso are diﬀerent from hIL-21, sig-
nal transduction ability of hIL-21iso on BAF21RWT-1 and
NK0 cells is quite similar to that of hIL-21. Since IL-21 has
very diverse functions on various immune cells, more research
based on this primary ﬁndings are needed to understand the
physiological function of this novel IL-21 isoform.
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